It uses peptides like GHK-Cu, BPC-157, and TB-500 to make skin look younger from the inside out
In a landmark Phase 2 obesity trial, participants receiving the highest dose achieved: Up to ~24% average weight loss at 48 weeks Weight loss had not yet plateaued at the end of the study Potential for even greater reductions with longer treatment duration For context: Semaglutide (GLP-1): ~15% weight loss Tirzepatide (GIP + GLP-1): ~2123% weight loss Retatrutide (GIP + GLP-1 + Glucagon): ~24%+ weight loss in Phase 2 studies Common side effects were similar to other GLP-1based therapies and included nausea, vomiting, diarrhea, constipation, and abdominal discomfort, primarily during dose escalation
Currently, the concentration of intracellular GSH is derived from either cell lysates or GSH- S -transferase (GST) dependent probes 7,8
Your doctor or pharmacist can usually recommend a suitable alternative
If approved, you receive a personalized treatment plan